140 related articles for article (PubMed ID: 15624289)
21. Influence of CYP2D6 genotype on the disposition of the enantiomers of venlafaxine and its major metabolites in postmortem femoral blood.
Kingbäck M; Karlsson L; Zackrisson AL; Carlsson B; Josefsson M; Bengtsson F; Ahlner J; Kugelberg FC
Forensic Sci Int; 2012 Jan; 214(1-3):124-34. PubMed ID: 21840145
[TBL] [Abstract][Full Text] [Related]
22. Simultaneous quantification of citalopram, clozapine, fluoxetine, norfluoxetine, maprotiline, desmethylmaprotiline and trazodone in human serum by HPLC analysis.
Waschgler R; Hubmann MR; Conca A; Moll W; König P
Int J Clin Pharmacol Ther; 2002 Dec; 40(12):554-9. PubMed ID: 12503813
[TBL] [Abstract][Full Text] [Related]
23. Serum concentrations of venlafaxine and its metabolites O-desmethylvenlafaxine and N-desmethylvenlafaxine in heterozygous carriers of the CYP2D6*3, *4 or *5 allele.
Hermann M; Hendset M; Fosaas K; Hjerpset M; Refsum H
Eur J Clin Pharmacol; 2008 May; 64(5):483-7. PubMed ID: 18214456
[TBL] [Abstract][Full Text] [Related]
24. Determination of venlafaxine and O-desmethylvenlafaxine in dried blood spots for TDM purposes, using LC-MS/MS.
Berm EJ; Brummel-Mulder E; Paardekooper J; Hak E; Wilffert B; Maring JG
Anal Bioanal Chem; 2014 Apr; 406(9-10):2349-53. PubMed ID: 24493333
[TBL] [Abstract][Full Text] [Related]
25. Determination of venlafaxine in human plasma by high-performance liquid chromatography using cloud-point extraction and spectrofluorimetric detection.
Qin XY; Meng J; Li XY; Zhou J; Sun XL; Wen AD
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Sep; 872(1-2):38-42. PubMed ID: 18675598
[TBL] [Abstract][Full Text] [Related]
26. Liquid chromatography tandem mass spectrometry method for the simultaneous stereoselective determination of venlafaxine and its major metabolite, O-desmethylvenlafaxine, in human plasma.
Dutta L; Ahmad SI; Mukherjee SK; Mishra S; Khuroo A; Monif T
Biomed Chromatogr; 2013 May; 27(5):622-35. PubMed ID: 23166015
[TBL] [Abstract][Full Text] [Related]
27. The pharmacokinetics of venlafaxine when given in a twice-daily regimen.
Troy SM; Parker VD; Fruncillo RJ; Chiang ST
J Clin Pharmacol; 1995 Apr; 35(4):404-9. PubMed ID: 7650231
[TBL] [Abstract][Full Text] [Related]
28. Simultaneous quantification of venlafaxine and O-desmethylvenlafaxine in human plasma by ultra performance liquid chromatography-tandem mass spectrometry and its application in a pharmacokinetic study.
Qin F; Li N; Qin T; Zhang Y; Li F
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Mar; 878(7-8):689-94. PubMed ID: 20133212
[TBL] [Abstract][Full Text] [Related]
29. Antidepressant polypharmacy and the potential of pharmacokinetic interactions: Doxepin but not mirtazapine causes clinically relevant changes in venlafaxine metabolism.
Paulzen M; Haen E; Hiemke C; Fay B; Unholzer S; Gründer G; Schoretsanitis G
J Affect Disord; 2018 Feb; 227():506-511. PubMed ID: 29156365
[TBL] [Abstract][Full Text] [Related]
30. Venlafaxine serum levels and CYP2D6 genotype.
Veefkind AH; Haffmans PM; Hoencamp E
Ther Drug Monit; 2000 Apr; 22(2):202-8. PubMed ID: 10774634
[TBL] [Abstract][Full Text] [Related]
31. Development and validation of a HPLC-MS/MS method for the determination of venlafaxine enantiomers and application to a pharmacokinetic study in healthy Chinese volunteers.
Liu W; Dai YC; Deng N; Liu XR; Yi Luo
Biomed Chromatogr; 2011 Mar; 25(3):412-6. PubMed ID: 21321974
[TBL] [Abstract][Full Text] [Related]
32. DETERMINATION OF VENLAFAXINE, VILAZODONE AND THEIR MAIN ACTIVE METABOLITES IN HUMAN SERUM BY HPLC-DAD AND HPLC-MS.
Petruczynik A; Wroblewski K; Szultka-Mlynska M; Buszewsk B; Karakula-Juchnowicz H; Gajewski J; Morylowska-Topolska J; Waksmundzka-Hajnosi M
Acta Pol Pharm; 2017 May; 74(3):765-775. PubMed ID: 29513945
[TBL] [Abstract][Full Text] [Related]
33. Distribution of venlafaxine and its O-desmethyl metabolite in human milk and their effects in breastfed infants.
Ilett KF; Kristensen JH; Hackett LP; Paech M; Kohan R; Rampono J
Br J Clin Pharmacol; 2002 Jan; 53(1):17-22. PubMed ID: 11849190
[TBL] [Abstract][Full Text] [Related]
34. Glycine functionalized multiwall carbon nanotubes as a novel hollow fiber solid-phase microextraction sorbent for pre-concentration of venlafaxine and o-desmethylvenlafaxine in biological and water samples prior to determination by high-performance liquid chromatography.
Ghorbani M; Chamsaz M; Rounaghi GH
Anal Bioanal Chem; 2016 Jun; 408(16):4247-56. PubMed ID: 27108286
[TBL] [Abstract][Full Text] [Related]
35. Serum and Saliva Concentrations of Venlafaxine, O-Desmethylvenlafaxine, Quetiapine, and Citalopram in Psychiatric Patients.
Ebert K; Maurice E; Lukačin R; Fleischhaker C; Schulz E; Ebert D; Clement HW
Ther Drug Monit; 2018 Jun; 40(3):351-355. PubMed ID: 29746434
[TBL] [Abstract][Full Text] [Related]
36. Distribution of venlafaxine, O-desmethylvenlafaxine, and O-desmethylvenlafaxine to venlafaxine ratio in postmortem human brain tissue.
Murrell MD; Cruz DA; Javors MA; Thompson PM
J Forensic Sci; 2014 May; 59(3):683-9. PubMed ID: 24502274
[TBL] [Abstract][Full Text] [Related]
37. Distribution and excretion of venlafaxine and O-desmethylvenlafaxine in human milk.
Ilett KF; Hackett LP; Dusci LJ; Roberts MJ; Kristensen JH; Paech M; Groves A; Yapp P
Br J Clin Pharmacol; 1998 May; 45(5):459-62. PubMed ID: 9643618
[TBL] [Abstract][Full Text] [Related]
38. Multiplexed quantification of venlafaxine and metabolites in human plasma by liquid chromatography-tandem mass spectrometry.
Pandey A; Price A; Ayala-Lopez N; Garza KY; Marzinke MA; Knezevic CE
J Pharm Biomed Anal; 2024 Jun; 243():116082. PubMed ID: 38461636
[TBL] [Abstract][Full Text] [Related]
39. Steady-state concentration of venlafaxine enantiomers: model-based analysis of between-patient variability.
Gex-Fabry M; Rudaz S; Balant-Gorgia AE; Brachet A; Veuthey JL; Balant LP; Bertschy G
Eur J Clin Pharmacol; 2002 Aug; 58(5):323-31. PubMed ID: 12185556
[TBL] [Abstract][Full Text] [Related]
40. Distribution of venlafaxine in three postmortem cases.
Levine B; Jenkins AJ; Queen M; Jufer R; Smialek JE
J Anal Toxicol; 1996 Oct; 20(6):502-5. PubMed ID: 8889688
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
